Literature DB >> 7534634

Thyroid cancer.

S Franceschi1, C La Vecchia.   

Abstract

Thyroid cancer is one of the rarest forms of cancer, and yet there are wide variations in the degree of malignancy, ranging from the most rapidly fatal to the relatively benign. This difference depends almost entirely on the histological type. A "pool" of individuals with occult thyroid carcinomas (in the vast majority of the papillary type) is probably present in most populations even at a young age. Large differences in the estimated frequency of cancer at this site can therefore be caused by variation in diagnostic intensity. Data on changing trends of incidence and mortality are thus subject to reservation, depending on the degree to which they have been influenced by changing diagnostic criteria and the precision of histopathological description. Nevertheless, there is evidence that mortality is slowly falling, whereas incidence is increasing, in several countries. This chapter considers the upward temporal trends of incidence and substantially stable mortality rates for thyroid carcinoma in the past three decades and attempts to interpret these trends in the light of concurrent changes in diagnostic standards and histological classification. Attention will also be drawn to the public health implications of the recent intensive detection and treatment of occult thyroid carcinomas.

Entities:  

Mesh:

Year:  1994        PMID: 7534634

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  3 in total

1.  Papillary microcarcinoma of the thyroid gland in renal transplant patients.

Authors:  B Nemes; A Zalatnai; H Podder; J Járay; P Sótonyi; Z Schaff; K Földes; F Perner
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Latent carcinoma of the thyroid in Austria: a systematic autopsy study.

Authors:  N Neuhold; H Kaiser; K Kaserer
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects.

Authors:  S Liu; R Semenciw; A M Ugnat; Y Mao
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.